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Serum sickness glomerulonephritis in rats. L. Arisz, B. Noble,
M. Mi/grom, J. R. Brentjens, andG. A. Andres. Departments of
Pathology, Microbiology and Medicine, State University New
York, Buffalo, New York, USA. Chronic serum sickness in rats
has been reported to develop after 6 months of weekly i.v. anti-
gen injections. However, death from anaphylaxis during the in-
duction of disease proved to be a major problem. In the present
study, female Fisher rats were immunized s.c. with bovine
serum albumin (BSA) in adjuvant. All rats responded with high
titers of anti-BSA antibodies. Subsequently, small, but gradually
increasing amounts of BSA were injected i.p., and within a few
days a gradual shift was made to daily i.v. BSA injections. With
this procedure, death from anaphylaxis was prevented. Protein-
uria developed after 2 weeks of daily iv. BSA injections and
reached a maximum (mean, 150 mg/24 hr) 2 weeks later. All rats
had severe nephrotic syndrome. Seven days after the start of
daily i.v. injections, light microscopy of kidney biopsy speci-
mens showed slight mesangial proliferation and a mild increase
in mesangial matrix, and direct immunofluorescence (DIF) tests
showed mesangial deposits of IgG, BSA, and C3. In a later
phase, when the nephrotic syndrome had developed, a diffuse
proliferative and exudative GN was seen in all rats and DIF
showed granular deposits of IgG, BSA, and C3 along the gb-
merular capillary wall. On electron microscopic examination,
electron-dense deposits were observed along the glomerular
basement membrane, mostly in a subepithelial location. Five
weeks after the start of daily i.v. BSA injections DIF tests of
heart, lung, spleen, intestine, liver, peritoneum, and ovary
showed granular deposits of IgG, BSA, and C3. It is concluded
that serum sickness in rats is a reproducible model of immune
complex disease, associated with diffuse, proliferative glomeru-
lonephritis, and systemic deposition of antigen-antibody com-
plexes. This chronic serum sickness model in inbred animals
may have applications for the study of the mechanism of immune
complex disease.
Induction of an SLE-like syndrome by the abnormal T-B cell
interactions of the chronic graft-versus-host reaction (GVHR) in
mice. E. Gleichmann, E. H. van Elven, P. Issa, M. C. Lamers.
Central Laboratory Blood Transfusion Service and Free Univer-
sity, and Departments of Immunohislopathology and Autoim-
mune Diseases of the Central Laboratory of the Netherlands
Red Cross Blood Transfusion Service and Laboratory of Experi-
mental and Clinical Immunology of the University of Amster-
dam, and International Immunology Training and Research
Centre, Amsterdam, The Netherlands. In addition to the forma-
tion of autoantibodies against red blood cells, lymphocytes, and
nuclear antigens, an immune complex glomerulonephritis
(ICGN) occurs in F1 mice undergoing a chronic GVHR. This
ICGN is initiated by reactions of donor-strain T lymphocytes to-
ward incompatible structures determined by the F1 hybrid recipi-
ents' major histocompatibility complex (MHC). The antibodies
in the glomerular immune complexes are produced by the stimu-
lated B cells of the recipient. The presumed pathogenetic mecha-
nism of autoimmunization in this model is a strong polyclonal
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stimulation of F1 B cells, the autoreactive B cells included, by
the positive allogeneic effect. We now report the induction of
autoantibodies also to double-stranded DNA (d5DNA) with Cri-
thidia luciliae as antigenic substrate for their demonstration.
Free anti-dsDNA antibodies were detected in the serum of up to
83% (C57BL/l0 x DBAI2) F1 recipients, which had received to-
tal dosages of 240 x 106 DBA/2 spleen, lymph node, and thymus
cells. When backcrosses between F1 and DBA/2 mice were used
as recipients of DBA/2(H.2) lymphocytes, only the H-2 in-
compatible recipients (H2t) developed anti-dsDNA antibodies.
Anti-dsDNA antibodies belonged to various Ig classes (IgG1,
IgG2, 1gM), occurred in titers of up to 1: 320, and carried the Ig
U' allotype characteristic of the F1 recipient, which defined them
as autoantibodies. There seems to be a relationship between the
formation of antibodies to dsDNA and the development of
ICGN. In light of the "altered self" concept, we have postu-
lated that GVH-like T-cell anti-MHC reactions and, con-
sequently, autoimmune diseases might be triggered in autologous
systems, if self MHC structures were rendered "foreign" by cer-
tain viruses or drugs.
Glomerulonephritis models and human pathology. P. J. Hoede-
maeker, G. J. Fleurew, J. Grond, J. J. Weening, and W. W. Bak-
ker. University Hospital, Groningen, The Netherlands. The
study of the acute serum sickness model has attributed much to
the understanding of the pathogenesis of the acute glomerulone-
phritis in men. On the basis of this and other models, it is as-
sumed that glomerulopathies are caused by glomerular immune
complex depositions from Ihe circulation. In the autologous im-
mune complex glomerulopathy (AIC) originally described by
Heymann et al, the immune complexes consisting of brushborder
antigens and their antibodies are localized exclusively at the epi-
thelial side of the GBM. Since in earlier studies we demonstrated
the presence of brushborder antigens in the GBM and showed
that in heterologous immune complex glomerulopathy the gb-
merular immune aggregates are formed in situ, it seemed worth-
while to investigate whether such a pathogenetic mechanism is
also operating in AIC. To study this, we perfused rat kidneys
with 10 mg of IgG eluted from kidneys with AIC and sub-
sequently reconnected to the circulation during time intervals
varying from 4 hours to 4 days. The results show that in absence
of circulating antigen, the perfused IgG binds to glomerular
structures in the same way as can be observed in early phases of
AIC. Control IgG did not bind to the GBM, and perfusion with
immune complexes consisting of Fx1A, and heterologous anti-
Fx1A resulted in a mesangial deposition. Since Fx1A antigens
also can be found in cell membranes of other organs, these results
indicate that antigen-sharing between GBM and other parts of
the body might be important in the induction of a glomerulopa-
thy. An immune reaction eisewhere in the body could result in
glomerulopathy if the antigens involved are also present in the
GBM. Because AIC resembles morphologically and clinically
the human membranous glomerulopathy, arguments in favor for
an in situ formation of immune complexes in this disease, espe-
cially in the membranous glomerulopathy associated with epithe-
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hal malignancies, are discussed. It is important to realize that
next to glomerular deposition of circulating immune complexes
at least one alternative pathogenetic mechanism for glomerulo-
nephritis exists in experimental models and possibly also in cer-
tain human glomerulopathies.
Effect of sensitization with highly purified erythrocytes on the
survival of rat renal allografts. G. D. Majoor and P. J. C. Van
Breda Vries,nan. Department of Immunopathology, Biomedical
Center, University of Limburg, Maastricht, The Netherlands.
Male inbred Brown Norway (BN) rats were used as recipients,
and male Lewis (LEW) rats were used as donated kidneys. High-
ly purified LEW erythrocytes (less than I leukocyte per l0
erythrocytes) were used for sensitization. Intravenous adminis-
tration of LEW erythrocytes to BN rats resulted in an 1gM and
IgG response or no response as determined by direct and indirect
hemagglutination techniques. The response depended on the
number of erythrocytes, the age of the recipient, and the fre-
quency of antigenic challenge. The alloantibody response of re-
cipients of renal allografts was measured serologically with both
direct and indirect hemagglutination techniques; in addition, im-
munofluorescence studies of the graft for 1gM, IgA, IgG and C3
were performed with indirect immunofluorescent techniques.
LEW allografts inserted into sensitized BN recipients during the
1gM response were rejected 2 days later (mean rejection time
[MRT], 9.4 days) compared to LEW allografts inserted into un-
sensitized recipients (MRT, 7.4 days). Binding of BN 1gM anti-
LEW erythrocyte antibodies to LEW grafts was demonstrated
on the second day postoperatively by finding 1gM deposited in
the grafts and a drop in titer of hemagglutinating 1gM antibody in
the serum of BN recipients. LEW allografts inserted into sensi-
tized BN recipients during the IgG response were rejected in a
slightly accelerated fashion (MRT, 6.4 days) when compared to
controls. Binding of BN IgG anti-LEW erythrocyte alloanti-
bodies to the grafts was likely since the titers decreased by 2.5
doubling dilutions on the second day postoperatively. LEW re-
nal allografts inserted into nonresponder BN rats were rejected
considerably later (RT, 13 to 96 days) than grafts in untreated
controls. Hemagglutinating alloantibodies could not be found
prior to or after transplantation. We showed that alloantibodies
against antigens which are being shared by erythrocytes and kid-
neys only slightly influence renal ahlograft survival. If, however,
the response to these alloantigens is suppressed, marked en-
hancement is observed.
Minimal lesions and focal sclerosis (FSGHS). M. S. Schilthuis,
L. Arisz, J. D. Elema, and G. K. V. D. Hem. Department of
Pathology and Medicine, University Hospital, Groningen and
Binnengasthuis, Amsterdam, Netherlands. To investigate a pos-
sible relationship between minimal lesions (ML) and focal seg-
mental glomerular hyalinosis and sclerosis (FSGHS), we eval-
uated selectivity of proteinuria (CIgG/Ctransf x 100%), reaction
to steroid therapy, and findings in follow-up biopsies in 38 ML
and 27 FSGHS patients. All ML patients with a steroid respon-
sive proteinuria (23/38, decline to less than 1 g/24 hr) went even-
tually into complete remission; most had a selective proteinuria
(22/23, <20%). ML patients with an incomplete steroid respon-
sive (decline to 1 to 3 g/24 hr) or steroid resistent proteinuria (14/
37) had frequently a nonselective proteinuria (8/14, s 20%. Fol-
low-up biopsies of 6/8 patients showed FSGHS. FSGHS patients
with a steroid resistent proteinuria (15/27) had at onset or later a
nonselective proteinuria (13/15). Of the FSGHS patients, 3/27
had a highly selective proteinuria (<10%). Two out of three pa-
tients showed a good response to steroid therapy (decline to
<1 g/24 hr) and followed a course classical for ML. Of 11 FSGHS
patients with a selectivity of 10 to 20%, 2 patients had initially a
partial response to therapy (proteinuria, 50%), but later they
became steroid resistent with a nonselective proteinuria (t20%).
It is concluded that: (1) there is an overlap for selectivity, reac-
tion to therapy, and clinical course between ML and FSGHS, (2)
ML patients with a nonselective corticosteroid-resistent protein-
una often change into FSGHS, (3) FSGHS has a variable clinical
course. Since it is reported that FSGHS lesions are present in
other forms of nephrotic syndrome, the lesion should be re-
garded as a nonspecific histopathologic entity, possibly second-
ary to proteinuria, or nephrotic syndrome, or both. The use of
'focal sclerosis" as a diagnosis has to be avoided. Proposed is to
use instead the term "minimal lesions with FSGHS." Protein-
uria may be selective with good response to steroids.
Treatment of moderate and severe hypertension with minoxidil.
T. Thien, F. T. M. Huysmans, K. van Leeuwen, R. G. W. L.
Tiggeler, J. G. M. C. Rosier, and R. A. P. Koene. St. Radboud
University, N(jmegen, The Netherlands.The antihypertensive ef-
fects of the new vasodilator minoxidil were studied in 24 patients
(17 males and 7 females) with a mean age of 41 years (range, 19 to
64). The cause of hypertension was nephrogenic in 14, reno-
vascular in 3, and essential in 7. In 17 out-clinic patients with
moderate hypertension, minoxidil was added to chlorthahidone
(100 mg daily). Blood pressure readings before addition of mm-
oxidil (means of the readings at three different visits) were supine
164/112 and standing 161/116mm Hg. On minoxidil (26mg daily)
these values were 156/90 and 148/94 mm Hg, respectively. Supine
heart rate increased from 82 to 91 beats/mm. Addition of a /3-
adrenergic blocking agent in 11 out of the 17 patients resulted in a
further decrease to supine 137/86 and standing 134/91 mm Hg,
with a decrease of supine heart rate to 74 beats/mm. This anti-
hypertensive effect remained unaltered during a mean follow-up
of 2 years with only minor changes in drug dosage. In seven pa-
tients who had severe hypertension, despite combined treatment
with /3-blockers, diuretics, and oral diazoxide (300 mg daily),
minoxidil was introduced after withdrawal of diazoxide. Blood
pressure readings before minoxidil were: supine 209/131 and
standing 200/131 mm Hg. During a mean follow-up of 10.4
months on minoxidil (mean, 49 mg daily) there appeared to be a
better control of hypertension, the pressures being 171/104 and
166/104, respectively. The tachycardia that developed in patients
on minoxidil and diuretics only was easily treated with /3-block-
ing drugs. The almost obligatory weight gain by sodium retention
responded to diuretic therapy in all patients. The most important
side-effects were hypertrichosis (83%) and nausea (33%). Tran-
sient increases in serum creatinine and serum lactic dehy-
drogenase levels were observed. The first is related to the drop in
blood pressure; the second remains unexplained. None of the
patients showed electrocardiographic changes, nor were there
clinical or echocardiographic signs of pericardial effusion. Mm-
oxidil is a welcome addition to the therapeutic armamentarium in
severe hypertension. Unlike sympathicolytic drugs, it does not
induce orthostatic hypotension. It seems slightly more potent
than diazoxide, but lacks the undesirable diabetogenic action of
this latter drug.
Wegener's granulomatosis: A clinicopathologic study in 12 pa-
tients. F. J. van der Woude, L. Arisz, S. Meijer, A. J. M. Donker,
P. J. Hoedemaeker, and J. J. M. van Overbeek. University Hos-
pital, Groningen, The Netherlands. Generalized Wegener's
granulomatosis (WG) is a distinct entity within the group of sys-
temic vascuhitis syndromes, characterized by granuloma forma-
tion in the respiratory tract and by glomerulonephritis. The 12
patients in this retrospective study all showed involvement of
upper airways and lungs; focal and local glomerulonephritis was
observed in 10. The sequence of organ involvement in these pa-
tients was variable. Usually, upper and lower respiratory tract
disease preceded glomerulonephritis. However, three patients
had acute renal failure at first presentation, and in one of them
renal disease was the only manifestation of WG during a period
of 6 months. Detailed examination of the upper airways, includ-
ing radiologic, endoscopic, and histopathologic studies, often
proved helpful in establishing an early diagnosis. Renal histology
was fairly characteristic. Local glomerular necrosis, focal forma-
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tion of crescents, interstitial infiltration, and occasionally gran-
uloma-like configurations around glomeruli were observed. Im-
munofluorescent studies of glomeruli in 10 patients were consis-
tently negative for immunoglobulins and C3. In 6 patients,
rheumatoid factor tires were strongly positive during active dis-
ease, and negative during clinical remission. Possibly, immune
complexes containing immunoglobulins with rheumatoid factor
activity are of pathogenic significance in the induction of vascu-
litis. Treatment with immunosuppressive drugs produced a good
response in nearly all patients. It is suggested that WG is more
common than is generally assumed. Early recognition and treat-
ment of the disease are important, because irreversible damage
to organs involved can thus be prevented.
Elimination of immune complexes by mononuclear phagocytes.
L.A. van Es, A. Kijistra, M. R. Daha, andi. de Graeff. Depart-
ment of Nephrology, University Hospital, Leiden, The Nether-
lands. To study the role of the mononuclear phagocyte system in
the protection against immune complex (ICx) deposition in ves-
sel walls, we investigated the factors which may influence ICx
elimination. The influence of Fc-receptors on the elimination of
ICx was studied experimentally with two heterologous IgG's,
one (guinea pig IgG2) which interacts strongly and another (goat
IgG) which interacts weakly with the Fc-receptors of rat mono-
nuclear phagocytes. Soluble ICx of similar composition, pre-
pared from denitrophenolated bovine thyroglobulin (DNP-BTG)
and either purified guinea pig IgG2 or goat IgG anti-DNP anti-
bodies (Ab), were injected i.v. into groups of rats. It appeared
that ICx prepared with goat Ab disappeared at the same rate as
DNP-BTG alone, whereas ICx prepared with guinea pig IgG2
were removed faster than antigen alone. The majority of the ICx
was removed by the liver. The influence of the number of IgG
molecules per complex on the elimination rate was studied with
stable IgG aggregates of restricted size, prepared by heat aggre-
gation and ultracentrifugation on sucrose density gradients con-
taining 0.5% bovine serum albumin. Aggregates containing a
mean of 15 molecules of guinea pig IgG2 A-(IgG2)15 disappeared
considerably faster (V/2, 2.6 mm) than monomeric goat or guinea
pig IgG or goat (IgG)15 (tV2 > 60 mm). Increasing the number of
IgG2 molecules per aggregate resulted in higher disappearance
rates: tV2 for A—(IgG2)29 = 1.96 mm. The highest rate was ob-
served for A—(IgG2)42, which was removed at the same rate as
A—(IgG2)106: t'/2 = 1.2 mm. The role of complement in the remov-
al of ICx was studied in vitro by incubating stable radiolabeled
guinea pig A-(IgG2)43 with guinea pig peritoneal macrophages for
1 hour at 370 C. In the absence of fresh serum, 29% of the aggre-
gates were catabolized, whereas 50% of the aggregates were ca-
tabolized when fresh serum was added. This stimulating effect
was not observed with C4- or C3-deficient serum but could be
induced by adding purified guinea pig C4 or C3, respectively.
Extrapolating our findings to the pathogenesis of ICx disease, we
would predict that ICx which cannot interact with the Fc- or C3-
receptors of mononuclear phagocytes will remain in the circula-
tion longer and will be deposited in vessel walls more easily.
